- Report
- January 2026
- 362 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 461 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 483 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 138 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 474 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 367 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 270 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 470 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 388 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 377 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 268 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 458 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 283 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 469 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 382 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 376 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 372 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 276 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 285 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 204 Pages
Global
From €5217EUR$5,850USD£4,523GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more